NASDAQ
Bicycle Therapeutics plc (BCYC) has a free cash flow growth of -286.62% as of Friday, May 29, 2026. This represents a 63.75% decrease compared to its 12-month average of -175.04%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.